SPECT imaging revealed that cocaine addicted subjects and control subjects differ in subcortical, limbic and cortical response to cholinergic probes in areas relevant to craving, learning and memory; findings that could result in new treatment options for individuals addicted to cocaine, according to a study published in the June issue of Neuropsychopharmacology.
Spatial patterns detected using a support vector machine may help further exploration of the specific genetic and neuropathological underpinnings of autism spectrum disorder in adults, and can potentially provide new insights into the multifactorial etiology of the condition, according to a study published online Aug. 11 in the Journal of Neuroscience.
Scientists at the Alzheimer's Association International Conference on Alzheimer's Disease in Honolulu this week presented the first draft reports from three workgroups convened by the National Institute on Aging and the Alzheimer's Association to update the diagnostic criteria for Alzheimer's disease for the first time in 25 years.
Syntermed launched NeuroQ version 3.5, a nuclear medicine quantitative software platform for analysis and image display of brain FDG-PET scans at the Alzheimer’s Association 2010 international conference this week in Honolulu.
Siemens PET/CT imaging technology, the Biograph mCT has been selected by the National Intrepid Center of Excellence for Psychological Health and Traumatic Brain Injury, which opened last week in Bethesda, Md.
Visual assessment of 11C-PIB images showed the best combination of sensitivity and specificity and holds promise as a supportive diagnostic marker for Alzheimer's disease, according to a study published June 11 in the Journal of Neurology, Neurosurgery and Psychiatry.
A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trials was released by the Coalition Against Major Diseases. This database will combine clinical trials to be shared by pharmaceutical companies and made available to researchers.
Tailored strategies based on the characteristics of research participants, including gender, age and family history, as well as willingness to pay for a quality-adjusted life-year (QALY), are required to address the problem of incidental findings in functional MRI studies, according to research published online in Value of Health on June 18.
Two new genetic factors, in addition to previously studied genetic variants, may be associated with the development and progression of Alzheimer’s disease, and there may be an association between genetic factors and neuroimaging traits, according to a study completed at Massachusetts General Hospital in Boston and published June 14 in the Archives of Neurology.
Chester A. Mathis, PhD, director of the PET facility in the department of radiology at the University of Pittsburgh, has received this year’s Paul C. Aebersold award, granted by SNM for his work with early detection in Alzheimer’s disease during its annual meeting in Salt Lake City.
Hanley Center, a nonprofit addiction treatment center, is planning to use SPECT scans to capture brain images of patients with alcohol and drug addiction, as well as to design more effective patient treatment programs.
While fitted average patient sizes are age dependent, predicted individual patient size does not correlate well with age on CT images, said the results of a study published in the June edition of the American Journal of Roentgenology, aimed at modeling optimal x-ray exposure factors in children.
An 18F-labeled PET amyloid-beta imaging agent, 18F-AV-45 is well tolerated in humans with no serious adverse events and may be a robust imaging tool and potentially well suited as a biomarker for Alzheimer disease in large multicenter treatment, according to trial results published in the June issue of the Journal of Nuclear Medicine.
Imperial College, London and McGill University of Montreal have entered an agreement enabling them to work more closely together in neurological research and clinical care.
PET imaging with tracer C-11 PK-11195(PK) identified that children with Niemann Pick disease type C have an underlying neuroinflammation, according to a presentation at the Molecular Neuroimaging Symposium this week in Bethesda, Md.
Research published in Nanotechnology suggests that small nanocomposite, made of both magnetic and fluorescent nanoparticles have been developed that may enhance the appearance of brain tumors as well as make it easier for surgeons to identify and remove glioblastomas.
The FDA has granted 510(k) clearance for Medtronic’s PoleStar N30 Surgical MRI system for neuro-oncology surgical procedures. The company simultaneously launched the imaging system.
A multicenter phase 2 study has found that 18F-flutemetamol PET is a potential biomarker for AD-related amyloidosis, according to the results presented on April 16 at the American Academy of Neurology (AAN) conference in Toronto.
The medial prefrontal cortex of the brain may be heavily involved in the processes of self-evaluation in humans and body size may play a dominant role in schematic representations of self-worth for many women, according to a study published in the May edition of psychological journal Personality and Individual Differences.
Loss of lean mass--the weight of an individual’s bones, muscles and organs without body fat--is accelerated in patients with Alzheimer’s disease (AD) and is associated with brain atrophy and cognitive performance, according to a study published in the April issue of the Archives of Neurology.
|